NEW YORK (GenomeWeb) – With its recent agreement to acquire Ambry Genetics for $1 billion, Japanese digital technology firm Konica Minolta is looking to move more heavily into the life science space, with a particular emphasis on precision medicine.
NEW YORK (GenomeWeb) – With its recent agreement to acquire Ambry Genetics for $1 billion, Japanese digital technology firm Konica Minolta is looking to move more heavily into the life science space, with a particular emphasis on precision medicine.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.